MANAGEMENT, SURVEILLANCE PATTERNS, AND COSTS ASSOCIATED WITH LOW-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Bree, Kelly
Shan, Yong
Hensley, Patrick
Lobo, Niyati
Hu, Chengrui
Tyler, Douglas
Chamie, Karim
Kamat, Ashish
Williams, Stephen
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP39-10
引用
收藏
页码：E669 / E669
页数：1
相关论文
共 50 条
  • [1] Management, surveillance patterns, and costs associated with low-grade Papillary (Ta) non-muscle invasive bladder cancer
    Bree, K. K.
    Shan, Y.
    Hensley, P. J.
    Lobo, N.
    Hu, C.
    Tyler, D. S.
    Chamie, K.
    Kamat, A. M.
    Williams, S. B.
    EUROPEAN UROLOGY, 2022, 81 : S236 - S236
  • [2] Management, surveillance patterns, and costs associated with low-grade papillary (Ta) nonmuscle-invasive bladder cancer.
    Bree, Kelly K.
    Shan, Yong
    Hensley, Patrick J.
    Lobo, Niyati
    Hu, Chengrui
    Tyler, Douglas S.
    Chamie, Karim
    Kamat, Ashish M.
    Williams, Stephen B.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [3] BENEFITS AND COSTS OF ALTERNATIVE GUIDELINES FOR SURVEILLANCE OF LOW-GRADE (LG) NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Su, Zhuo T.
    Mahon, Katherine
    Rezaee, Michael
    Patel, Sunil
    Townsend, Jeffrey
    Kates, Max
    JOURNAL OF UROLOGY, 2024, 211 (05): : E941 - E941
  • [4] Patterns in the Management of Low-Grade Non-Muscle-Invasive Bladder Cancer-the Human and Economic Costs of Excessive Surveillance
    Cook, Grayden S.
    Howard, Jeffrey M.
    JAMA NETWORK OPEN, 2022, 5 (03)
  • [5] Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non-Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013
    Bree, Kelly K.
    Shan, Yong
    Hensley, Patrick J.
    Lobo, Niyati
    Hu, Chengrui
    Tyler, Douglas S.
    Chamie, Karim
    Kamat, Ashish M.
    Williams, Stephen B.
    JAMA NETWORK OPEN, 2022, 5 (03)
  • [6] Re: Management, Surveillance Patterns, and Costs Associated with Low-grade Papillary Stage Ta Non-muscle-invasive Bladder Cancer Among Older Adults, 2004-2013
    Zlotta, Alexandre R.
    EUROPEAN UROLOGY, 2023, 83 (01) : 92 - 93
  • [7] Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial
    Azawi, Nessn
    Vasquez, Juan Luis
    Dreyer, Thomas
    Guldhammer, Cathrine Silberg
    Saber Al-Juboori, Rami Muthanna
    Nielsen, Anna Munk
    Jensen, Jorgen Bjerggaard
    CANCERS, 2023, 15 (08)
  • [8] Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer
    Zaurito, Paolo
    Scilipoti, Pietro
    Longoni, Mattia
    de Angelis, Mario
    Re, Chiara
    Quarta, Leonardo
    Tremolada, Giovanni
    Burgio, Giusy
    Pellegrino, Francesco
    Rosiello, Giuseppe
    Necchi, Andrea
    Colombo, Renzo
    Gandaglia, Giorgio
    Salonia, Andrea
    Montorsi, Francesco
    Briganti, Alberto
    Moschini, Marco
    WORLD JOURNAL OF UROLOGY, 2024, 43 (01)
  • [9] The Costs of Non-Muscle Invasive Bladder Cancer
    James, Andrew C.
    Gore, John L.
    UROLOGIC CLINICS OF NORTH AMERICA, 2013, 40 (02) : 261 - +
  • [10] STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer
    Taber, Ann
    Park, Youngrok
    Lelo, Alana
    Prip, Frederik
    Xiao, Jerry
    Berry, Deborah L.
    Chaldekas, Krysta
    Jensen, Jorgen Bjerggaard
    Philips, George
    Kim, Jung-Sik
    Harris, Brent T.
    Dyrskjot, Lars
    Waldman, Todd
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (07) : 438.e1 - 438.e9
12345